14C Radiolabelling

Almac has extensive experience in the synthesis and analysis of stable (non radio-active) and 14C isotope labelled compounds – from drug discovery through to launch – we can label any compound at any stage, including small molecules, peptides and larger bio molecules.

Our custom radiolabelling service encompasses QC and analytical support, including method development and validation, method transfer and radiolabelling stability studies from our state-of-the-art facilities.

We are MHRA certified for 14C IMP manufacture and GMP compliance and we are fully equipped to deliver an industry-leading, cost-effective radiolabelling service.

Isotopic labelling imposes many synthetic challenges beyond those found in normal chemical synthesis. When the isotope is radioactive, this becomes even more demanding. That’s why we offer advice on the most appropriate label position for your molecule, including feasibility and metabolic stability.